• OFID 2017:4 (Suppl 1) • Poster Abstracts lesion and 86.2% had ≤ 3 lesions with a median = 2 cm (IQR 1-2). Lesions presented predominantly on upper limbs (40.9%), followed by lower limbs (23.2%). According to PAHO and WHO criteria, 18% (12.3% adult vs. 19.3%, P = 0.007) and 44.4% (adolescents 42% vs. adults 43%, P = 0.45), respectively, were eligible for local therapies.
Background. Bacteremic brucellosis is an acute febrile disease often associated with digestive complaints and biological inflammatory syndrome. In this perspective, our study aimed to determine predictive factors of bacteremia in patients with brucellosis.
Methods. We conducted a retrospective study including all patients hospitalized with brucellosis between 1990 and 2014.
Results. We included 161 cases of brucellosis among which bacteremia was documented in 30 cases (18.6%). Mean age was of 39.6 ± 17 years. Brucella melitensis was solely isolated. In bacteremic brucellosis, there were more fever (93.3% vs. 78%; P = 0.049; HR=4), nausea (16.7% vs. 4.6%; P = 0.033; HR = 4.2), and splenomegaly (20% vs. 7.6%; P = 0.049; HR = 3). The acute form was significantly more common in bacteremic brucellosis (66.7% vs. 42%; P = 0.015; HR = 2.7). Bacteremic brucellosis patients had a significantly higher frequence of anemia (76.7% vs. 51.6%; P = 0.013; HR=3.2) and higher C-reactive protein value (85.5 ± 45 vs. 35 ± 20 mg/L; P < 0.001). Commonly used antimicrobial regimens consisted of rifampicin plus doxycycline given for 6 weeks in both bacteremic and non-bacteremic brucellosis (86.7% vs. 72%; P = 0.1). A favorable outcome was significantly associated with bacteremic brucellosis (73.3% vs. 52%; P = 0.03; HR=2.38). Multivariate analysis using logistic regression revealed that the presence of nausea (HR = 9; CI95% 14-60; P = 0.002), acute form of brucellosis (HR = 4.5; CI95% 1.2-17; P = 0.025) and C-reactive protein value (HR = 1.12; CI95% 1.1-1.2; P = 0.02) were independent predictors of bacteremic brucellosis.
Conclusion. Our study highlighted clinical and biological particularities of bacteremic brucellosis which may help clinicians to establish a prompt diagnosis and suitable treatment, two main conditions to improve patients' prognosis.
Disclosures. Background. Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, is endemic to Texas and has significant morbidity associated with its cardiac pathology. The Joint Base San Antonio-Lackland (JBSA) represents a healthcare system with universal coverage to its beneficiaries and its blood bank screens all firsttime blood donors for T. cruzi infection. Although there is a published, standardized approach for diagnosis and evaluation of Chagas disease in the United States, adherence to this approach has not been studied.
Methods. A retrospective chart review was performed on all persons who screened positive for T. cruzi on blood donation at JBSA from 2014 to 2016. Charts were reviewed to determine frequency and results of confirmatory testing, history and physical, EKG, and 30 second rhythm strip; outcomes of these evaluations were ascertained. Chagas disease was considered confirmed on the basis of positive EIA and TESA testing from the CDC and/or two different positive serologic tests.
Results. Of the 43,402 blood donors at JBSA, 23 screened positive for Chagas disease. Follow-up information was available on 22 (95.7%). Seventeen (77%) were military trainees and 18 (82%) were male. Patients had a mean of 2.5 (range 1-5) additional serologic tests, with 13 different combinations of confirmatory tests ordered, including 17 (77%) who had the initial screening test repeated. Two patients (9%), both from Texas, met criteria for Chagas disease. One of these was diagnosed with cardiomyopathy and underwent administrative separation from the Air Force. Eleven (50%) had Chagas disease excluded on the basis of two negative follow-up tests, and 9 (41%) had one negative follow-up test. All underwent history and physical, 15 (68%) had an EKG, and 5 (22%) had a 30 second rhythm strip. Fourteen (64%) were referred to infectious diseases.
Conclusion. Among a small cohort of active duty service members who screened positive for T. cruzi infection on blood donation, diagnostic workup, and evaluation varied considerably, despite universal access to no-cost medical care within a single system. Opportunities exist within the military health system to decrease heterogeneity and to improve evaluation of persons who screen positive in the future. 
